Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

Donate
Sign Up
Main Menu

New Tool to Educate Your Community About Chronic Disease!

Introducing OMFCA’s Social Shareables Web Portal!

New tool to help educate your personal communities

As part of #TripleGivingTuesday, we are pleased to announce that we have developed a new tool to help you educate your personal communities about ME/CFS and related multisystem chronic, complex diseases (msCCD).

Check out our new Social Shareables site now!

Use our new Social Shareables page to download educational graphics about ME/CFS, Fibromyalgia, Long COVID, and Chronic Lyme Disease and share them on social media. The steps are easy: click on each image to download and post directly to Instagram, Twitter, and/or Facebook!

You can also follow OMF on our social media channels and share or retweet our informational content! (@OpenMedFCanada on Twitter and Instagram.) We hope you find this to be a valuable resource in helping the greater community understand ME/CFS and related multisystem chronic, complex diseases. Don’t forget to tag us (type ‘@OpenmedFCanada’), in your social shareables post so we can help you to get the word out! 

Want to connect with others within the chronic disease community? Try using these hashtags on your posts:

#SpoonieSupport #PwME #MillionsMissing #EndMECFS #SpoonieCommunity #Butyoudontlooksick #Chronicillness 

Announcing OMF's Featured Triple Giving Tuesday Artist!

Last month, we asked our community of people affected by multisystem chronic, complex diseases to submit their art for a chance to become OMF and OMFCA’s Featured Triple Giving Tuesday artist. 

We received so many amazing submissions — we are truly blown away by the creativity and talent of the community! We are excited to announce that our selected winner is Lee Stocker!

Lee explains, “I have suffered from moderate/severe ME/CFS for most of my adult life (I am now 48 years old). I enjoy painting mostly seascapes. I miss being able to travel to the sea, so I paint it instead. I suppose it’s a form of therapy. ME/CFS generally stops me physically going anywhere but my imagination takes me there when I paint. 

I mostly paint in soft pastels and watercolor, as they are generally “fast mediums.” This means I can produce a piece of artwork (when not brain fogged) before the post exertion malaise (PEM) kicks in.”

Congratulations, Lee! We hope people with chronic diseases worldwide can resonate and take comfort in the beautiful sea landscapes.  We also send our heartfelt gratitude to all those who submitted their work!

There’s no better time to support OMFCA’s critical mission than
Triple Giving Tuesday!

All donations received by OMFCA any day of the week will be TRIPLED until November 30, 2021. That means your gift of $10 = $30, and so on! Don’t miss out on this opportunity to triple your impact on research into related chronic, complex diseases.

Donate Now!

Consent management

Consent Preferences

Data Subject Access Request (DSAR) Form 

Microvesicles and viral sequencing
Microvesicles are a type of extracellular vesicle that is released from the cell membrane. Vesicles are small, fluid-filled sacs or vacuoles within the body. Sequencing is a technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA (or viral) molecule.
NMR Metabolomics
NMR (Nuclear Magnetic Resonance) is an instrument/tool used to perform metabolic studies, metabolic profiling, and metabolomics in biofluids and tissues for more than 40 years using magnetic fields. There is a very close connection between metabolic measurements and NMR. This connection has flourished because of NMR’s many unique strengths for characterizing complex mixtures’ chemical composition.
Proteomics
The large-scale study of proteins, which are large, complex molecules that are required for structure, function, and regulation of the human body's tissues and organs.
Immune cell profiling
The immune system has many important regulatory roles in disease development and progression. Given the emergence of effective immune therapies, reliable predictors of response are needed. Immune cell profiling determines response by evaluating immune cell populations from treated and untreated samples. For our purposes, we will evaluate the white blood cell response to the viral infection using a process called “Cytof.”
Leukocyte Genomics
A leukocyte is a colorless cell circulating in the blood and body fluids and is involved in counteracting foreign substances and disease. A genome is all genetic material of an organism. Genomics is a biology field focusing on the structure, function, evolution, mapping, and editing of genomes. Therefore, leukocyte genomics is the study of all genetic material of leukocytes.
Metabolomics
Metabolomics is a way to study metabolism – that is, through measuring amounts of the metabolites (small molecules) produced by our bodies as we convert food into energy and other molecules that our cells need to survive. Metabolomics technology is ‘large-scale,’ meaning that several thousand metabolites can be measured from a single sample of e.g., blood or urine.
Micro RNA
Cells use Micro RNA to control whether a particular gene is making too much, too little or the normal amount of its protein at a particular time.
Autoantibodies
Antibodies that react with self-molecules and that occur in healthy individuals and are referred to as natural antibodies or autoantibodies.
Extracellular DNA for viral reactivation and Mitochondrial DNA
exDNA (extracellular DNA), exDNA is often secreted actively and is used to perform several tasks, thereby offering an attractive target or tool for biotechnological, medical, environmental, and general microbiological applications. Viruses are intracellular parasites that rely to a significant extent on the host cell for replication. Viral reactivation occurs when an active replication of the viral genome results in a lytic (degradation of the cell) infection characterized by the release of new progeny (descendant) virus particles.